| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.4 | 0.003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |